Pfizer's Acquisition of Seagen Receives Regulatory Approvals
Pfizer Inc. has received regulatory approvals and commits to donating Bavencio sales royalties to cancer research. They plan to enhance collaboration...
Pfizer Inc. has received regulatory approvals and commits to donating Bavencio sales royalties to cancer research. They plan to enhance collaboration...
Consider investing in corporate debt, specifically high-yield bonds, as a stable alternative to stocks, offering attractive returns and mitigating ris...
Pasithea Therapeutics announces encouraging preclinical results for PAS-004 in lung and liver cancer xenograft models, with superior anti-tumor effica...
Schibsted plans to split into two entities, transferring news media to largest shareholder and keeping marketplaces publicly listed. This move aims to...
Not all stock buybacks result in significant returns for investors. Learn about the impact of buybacks on shareholder value and successful strategies...
Catalent, a leading drug manufacturer, reports revisions in its financial results with a significant impairment charge of nearly $700 million.
Yields on 2-year, 10-year, and 30-year Treasuries rise ahead of employment report, impacting bond markets. Forecast aligns with U.S. economic growth a...
Special purpose acquisition company Thunder Bridge Capital Partners III has decided to liquidate and redeem shares of Class A common stock. The compan...
Lululemon Athletica continues to show strong sales growth in Q3, with $2.2 billion revenue and positive outlook for Q4.
AerSale's revolutionary AerAware system, developed in collaboration with Universal Avionics, receives FAA certification, improving flight safety and o...